Literature DB >> 1949017

Relationship of hepatocarcinogenicity and hepatocellular proliferation induced by mutagenic noncarcinogens vs carcinogens. II. 1- vs 2-nitropropane.

M L Cunningham1, H B Matthews.   

Abstract

2-Nitropropane (2-NP) is mutagenic in a number of short-term mutagenicity assays in vitro and in vivo, and is a potent hepatocarcinogen in rats. A structural isomer, 1-nitropropane (1-NP), is mutagenic in V79 cells and can induce unscheduled DNA synthesis in rat hepatocytes, yet did not induce tumors in rats following chronic exposure. We examined the correlation of cell proliferation and hepatocarcinogenesis induced by this mutagenic noncarcinogen-carcinogen pair in a rat liver proliferation model. Rats were exposed to gavage doses of 0.5, 1, or 2 mmol/kg of 1-NP or 2-NP daily for 10 days; the highest two dose groups were similar to the doses used in the carcinogenesis bioassay. Cell proliferation was quantitated by incorporation of bromodeoxyuridine, detected immunohistochemically, into newly synthesized DNA. Animals exposed to the vehicle exhibited a labeling index (LI) of approximately 1.9% and animals exposed to CCL4 had a LI of approximately 30%. Rats exposed to the hepatocarcinogen 2-NP exhibited a dose-related increase in LI to 6.3 and 11% at the 1 and 2 mmol/kg doses, respectively, and no increase above control at the 0.5 mmol/kg exposure level. Animals exposed to the noncarcinogenic isomer 1-NP showed no statistically significant increase in LI above controls at any dose level tested. Serum chemistries were consistent with mild to moderate decreases in hepatocellular function, cholestasis, and necrosis following 2-NP exposure, but only minimal effects were observed, probably due to slight dehydration resulting from 1-NP exposure. These data indicate a positive association between increased cell proliferation and hepatocarcinogenesis induced by these two nitropropane isomers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949017     DOI: 10.1016/0041-008x(91)90050-o

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

1.  Assessment of the influence of subacute phenobarbitone administration on multi-tissue cell proliferation in the rat using bromodeoxyuridine immunocytochemistry.

Authors:  H B Jones; N A Clarke
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

2.  Concordance between Results of Medium-term Liver Carcinogenesis Bioassays and Long-term Findings for Carcinogenic 2-Nitropropane and Non-carcinogenic1-Nitropropane in F344 Rats.

Authors:  Yuko Doi; Seiko Tamano; Mayumi Kawabe; Masashi Sano; Norio Imai; Hironao Nakashima; Fumio Furukawa; Akihiro Hagiwara; Masanori Otsuka; Tomoyuki Shirai
Journal:  J Toxicol Pathol       Date:  2012-01-07       Impact factor: 1.628

3.  Chronic toxicity of chloroform to Japanese medaka fish.

Authors:  M W Toussaint; A B Rosencrance; L M Brennan; J R Beaman; M J Wolfe; F J Hoffmann; H S Gardner
Journal:  Environ Health Perspect       Date:  2001-01       Impact factor: 9.031

Review 4.  The causes and prevention of cancer: gaining perspective.

Authors:  B N Ames; L S Gold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

Review 5.  DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis.

Authors:  B N Ames; M K Shigenaga; L S Gold
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 6.  Anomalous nonidentity between Salmonella genotoxicants and rodent carcinogens: nongenotoxic carcinogens and genotoxic noncarcinogens.

Authors:  K Yoshikawa
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

7.  Site-specific cell proliferation in renal tubular cells by the renal tubular carcinogen tris(2,3-dibromopropyl)phosphate.

Authors:  M L Cunningham; M R Elwell; H B Matthews
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

8.  Correlation between thyroid hormone status and hepatic hyperplasia and hypertrophy caused by the peroxisome proliferator-activated receptor alpha agonist Wy-14,643.

Authors:  C Wang; J Youssef; ML Cunningham; M Badr
Journal:  J Carcinog       Date:  2004-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.